Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute - PubMed

Affiliations

• PMID: 9918573

Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute

W T Phillips et al. J Pharmacol Exp Ther. 1999 Feb.

Abstract

A major obstacle in the development of red cell substitutes has been overcoming their short circulation persistence. In this study, distearoyl phosphoethanolamine polyethylene glycol 5000 (PEG-PE) (10 mol%) was added to the formulation of liposome-encapsulated hemoglobin (LEH) to decrease reticuloendothelial system uptake and prolong LEH circulation persistence. PEG-LEH was radiolabeled with technetium-99m, infused into rabbits (25% of blood pool at 1 ml/min) (n = 5), and monitored by scintigraphic imaging at various times out to 48 h. At 48 h, animals were sacrificed, and tissue samples were collected for counting in a scintillation well counter. Tissue distribution data at 48 h revealed that 51.3 +/- 3.4% of the technetium-99m-PEG-LEH remained in circulation, a greater than 3-fold increase in the circulation half-life compared with circulation half-lives previously reported for non-PEG-containing LEH formulations. The liver had the greatest accumulation at 48 h (12.7 +/- 0.7%), followed by bone marrow (6.2 +/- 0.1%), whereas the spleen had only 1.4 +/- 0.2%. The addition of PEG-PE to the LEH formulation greatly prolongs the circulation persistence of LEH and represents a significant step in the development of red cell substitutes with prolonged oxygen delivery.

Similar articles

• Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics.

  Awasthi VD, Garcia D, Klipper R, Goins BA, Phillips WT. Awasthi VD, et al. J Pharmacol Exp Ther. 2004 Apr;309(1):241-8. doi: 10.1124/jpet.103.060228. Epub 2004 Jan 12. J Pharmacol Exp Ther. 2004. PMID: 14718581

• Kinetics of liposome-encapsulated hemoglobin after 25% hypovolemic exchange transfusion.

  Awasthi VD, Garcia D, Klipper R, Phillips WT, Goins BA. Awasthi VD, et al. Int J Pharm. 2004 Sep 28;283(1-2):53-62. doi: 10.1016/j.ijpharm.2004.06.015. Int J Pharm. 2004. PMID: 15363501

• Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.

  Sou K, Klipper R, Goins B, Tsuchida E, Phillips WT. Sou K, et al. J Pharmacol Exp Ther. 2005 Feb;312(2):702-9. doi: 10.1124/jpet.104.074534. Epub 2004 Sep 30. J Pharmacol Exp Ther. 2005. PMID: 15459236

• Liposome-encapsulated hemoglobin: an oxygen-carrying fluid.

  Rabinovici R, Rudolph AS, Ligler FS, Yue TL, Feuerstein G. Rabinovici R, et al. Circ Shock. 1990 Sep;32(1):1-17. Circ Shock. 1990. PMID: 2208604 Review.

• Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.

  Sakai H, Tsuchida E. Sakai H, et al. Clin Hemorheol Microcirc. 2006;34(1-2):335-40. Clin Hemorheol Microcirc. 2006. PMID: 16543654 Review.

Cited by

• Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ injuries in a rat model of hemorrhagic shock.

  Yadav VR, Rao G, Houson H, Hedrick A, Awasthi S, Roberts PR, Awasthi V. Yadav VR, et al. Eur J Pharm Sci. 2016 Oct 10;93:97-106. doi: 10.1016/j.ejps.2016.08.010. Epub 2016 Aug 5. Eur J Pharm Sci. 2016. PMID: 27503458 Free PMC article.

• Nanotechnology for computed tomography: a real potential recently disclosed.

  Anton N, Vandamme TF. Anton N, et al. Pharm Res. 2014 Jan;31(1):20-34. doi: 10.1007/s11095-013-1131-3. Epub 2013 Jul 30. Pharm Res. 2014. PMID: 23896738 Review.

• Hemoglobin-based Oxygen Carriers: Current State-of-the-art and Novel Molecules.

  Sen Gupta A. Sen Gupta A. Shock. 2019 Oct;52(1S Suppl 1):70-83. doi: 10.1097/SHK.0000000000001009. Shock. 2019. PMID: 31513123 Free PMC article. Review.

• Long-term effects on the histology and function of livers and spleens in rats after 33% toploading of PEG-PLA-nano artificial red blood cells.

  Liu ZC, Chang TM. Liu ZC, et al. Artif Cells Blood Substit Immobil Biotechnol. 2008;36(6):513-24. doi: 10.1080/10731190802554224. Epub 2008 Dec 9. Artif Cells Blood Substit Immobil Biotechnol. 2008. PMID: 19043818 Free PMC article.

• Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin.

  Awasthi V, Yadav VR, Goins B, Phillips WT. Awasthi V, et al. J Microencapsul. 2013;30(5):471-8. doi: 10.3109/02652048.2012.752535. Epub 2012 Dec 11. J Microencapsul. 2013. PMID: 23231644 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database